RECURSION PHARMACEUTICALS, INC. ($RXRX)
Filing Information
| Accession Number | 0001601830-26-000013 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 10, 2026 |
| Document Date | Feb 6, 2026 |
| Document | View SEC Filing |
Transactions
3
Total Shares
481,933
Total Value
$45,372.00
P&L
+inf% (+$1,529,232.25)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Class A Common Stock | โ | Feb 6, 2026 | Grant/Award | 446,279 | $0.00 | $0.00 | 1,207,829 | Direct | โ | View Details | |
Chief Financial Officer | Class A Common Stock | โ | Feb 6, 2026 | Grant/Award | 24,254 | $0.00 | $0.00 | 1,232,083 | Direct | โ | View Details | |
Chief Financial Officer | Class A Common Stock | โ | Feb 6, 2026 | Tax Withholding | 11,400 | $3.98 | $45,372.00 | 1,220,683 | Direct | โ | View Details |